U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.

Cover of StatPearls

StatPearls [Internet].

Show details

Migraine-Associated Vertigo

; .

Author Information and Affiliations

Last Update: August 19, 2022.

Continuing Education Activity

Patients often describe vertigo as the sensation of motion that occurs in the absence of motion or an altered sensation of motion that occurs with normal motion. In vertigo associated with vestibular migraines, the sensation is often described as "to-and-fro". Vestibular migraines are not always accompanied by concurrent headaches, so an in-depth history and multi-specialty evaluation are pivotal to make the correct diagnosis. This activity describes the pathophysiology, etiology, presentation, and management of vestibular migraines and highlights the role of the interprofessional team in improving care for affected patients.


  • Describe the pathophysiology of vestibular migraine.
  • Review the presentation of vestibular migraine.
  • Summarize the treatment options for vestibular migraines.
  • Explain the importance of enhancing care coordination amongst interprofessional team members to improve outcomes for patients affected by vestibular migraine.
Access free multiple choice questions on this topic.


Patients explain a sensation of motion when no motion is taking place or an altered sensation with a normal motion to define vertigo. In a vestibular migraine, the sensation is often described as a "to-and-fro" sensation, and this can complicate diagnosis. Simultaneous headaches do not always accompany the vestibular symptoms, thus making an in-depth history and multi-specialty evaluation pivotal in order to make a diagnosis.[1][2][3]

The International Headache Society in the International Classification of Headache Disorders, Second Edition classified a migraine into distinct diagnoses; however, only benign paroxysmal vertigo of childhood-type and basilar-type migraine included vertigo.[4] The Neuheuser criteria were historically the most widely accepted classifier of dizziness related to a migraine. It divided a vestibular migraine into "definite" versus "probable" disease.[5]

Definite vestibular migraine criteria included: 

  • At least 2 vestibular vertigo attacks
  • Migraine according to ICHD-II classification
  • Concomitant migrainous symptoms during at least 2 vertigo attacks (migraine headache, photophobia, phonophobia, visual or other auras) 
  • No evidence of other central or otological causes of vertigo

Probable vestibular migraine diagnostic criteria included: 

  • At least 2 vestibular vertigo attacks
  • At least 1 of the following:
  1. An ICHD-II migraine
  2. At least 1 migrainous symptom during at least 2 vertigo attacks (migrainous headaches, photophobia, phonophobia, visual or other auras)
  3. No evidence of other causes of vertigo[6]

In 2012, definite and probable diagnostic criteria were replaced with diagnostic criteria for a vestibular migraine put forth by both the Barany Society and the International Headache Society.[1][2] 

The currently accepted vestibular migraine diagnostic criteria consist of the following:

  • At least 5 episodes of vestibular symptoms of moderate or severe intensity lasting 5 minutes to 72 hours
  • Current or previous history of migraines with or without aura according to the ICHD classification
  • One or more of the following migraine features with at least 50% of vestibular episodes:
  1. Headache with at least 2 of the following characteristics
  2. One-sided location, pulsating quality, moderate or severe pain intensity; photophobia or phonophobia
  3. Visual aura
  • Not better accounted for by another vestibular or ICHD diagnosis[7]

Due to the relatively new diagnostic criteria, much of the reviewed literature is based on the Neuheuser criteria.


There is limited concrete evidence regarding the absolute etiology of vestibular migraine. However, genetics may play a role in vestibular migraines as displayed by a recent study showing an autosomal dominant inheritance trait linked to gene locus 5q35 in a four-generation family line. The majority of this family demonstrated headaches followed by vertigo within 15 to 20 years after the onset of migraine headaches.[8] Other studies have reported links to a region on chromosome 11q or 22q12.[9][10]

Many peripheral vestibular disorders are seemingly associated with a vestibular migraine, some of which include Meniere syndrome and benign paroxysmal positional vertigo.

Meniere Syndrome

While it seems Meniere syndrome is associated with vestibular migraine, the relationship appears complicated. Clinical evaluation of dizzy or vertiginous patients is commonplace at many tertiary otolaryngology centers. With the understanding of some selection bias, a study from one of these centers demonstrated nearly 30% of Meniere syndrome patients may also have vestibular migraine, while an additional 30% did not meet vestibular migraine criteria but did demonstrate some migraine-like qualities.[11]

An additional study showed some fascinating associations between Meniere syndrome and vestibular migraine. Thirteen percent to 18% of those initially diagnosed with probable or definite vestibular migraine developed bilateral, low-frequency sensorineural hearing loss within 9 years. Interestingly, 7% to 11% developed cochlear symptoms that met the American Academy of Otolaryngology, Head and Neck Surgery (AAO-HNS) criteria for bilateral Meniere syndrome.[6][12]

In 2013, Wise and Sargent presented that those who suffer from simultaneous migraine headaches with intractable Meniere syndrome experienced worse quality of life-related surgical outcomes compared to intractable Meniere syndrome alone. These findings were obtained after undergoing endolymphatic sac decompression for intractable Meniere syndrome.

The idea that one may suffer from both diseases cannot be discounted, and therefore ought to be considered in the workup and treatment. Additionally, due to similar symptomatology diagnostic uncertainty may confuse the patient regarding the actual disease with which they suffer.

Benign Paroxysmal Positional Vertigo (BPPV)

The association between BPPV and vestibular migraine is another complicated one as the relationship is not well understood. It has been shown that those with BPPV who are successfully treated with the Epley maneuver have a higher prevalence of motion sickness or migraine history compared to the general public.[13]

Further, a conglomerate of the symptoms of vertigo, nausea, and headaches accompanied by sustained nystagmus on positional testing that dissipates when the patient is symptom-free suggests a vestibular migraine.[14] Additionally, another study has suggested an association between the diagnoses of probable or definite a vestibular migraine and atypical positional nystagmus and/or vertigo.[6] Despite these suspected associations, singular canal or multiple canal cupulolithiasis ought to be excluded, as this may be a driving inducer for a vertigo-associated migraine.

Migraine Anxiety-Related Dizziness (MARD) 

MARD is a condition that must be considered as recurrent dizziness can cause debilitating anxiety. This disease is diagnosed with symptoms of anxiety, migraine, and vestibular symptoms. Treating anxiety as well as the migraine and balance disorder is a must.[15]


Vestibular migraine is most commonly noted in midlife with a predilection for females. There is a 5:1 female-to-male preponderance with the mean age of onset of 37 years for females and 42 years for males. Migraine typically predates the vertiginous symptoms. The mean age of onset of headaches is 28 years old and the mean age of dizziness onset is 49 years old.[16]


Little is known or understood regarding the pathophysiology of the disease, or at least there is little consensus of agreement. However, there are theories that vestibular symptoms may be an aura, an associated symptom to a headache, or due to actual peripheral vestibulopathy. In 2011, Eggers et al. reported vertigo in a vestibular migraine as an associated phenomenon rather than an aura.[16]

Another theory involves the idea of "kindling." Just as epileptic seizures may lower the threshold for future seizures, a similar thought process exists for vestibular migraines. The possibility that vestibular migraineurs become sensitized to stimuli such as motion in the visual field, and this may lead to recurrent vestibular migraine symptoms.[17]

Finally, one study showed that caloric testing triggers a migraine in some individuals. In this study, 39 individuals with a history of a migraine underwent caloric testing. Within 24 hours, 19 of these individuals developed their typical migraine symptoms. 47% of those that developed a migraine within 24 hours actually developed a migraine during testing. This study design used a matched control group and only one of 21 from this group developed a migraine within the initial 24-hour period after testing.[18] This finding is perplexing, leading one to believe that peripheral vertigo can be a trigger of a migraine or migraine-related symptoms.

History and Physical

Thirty percent of those diagnosed with vestibular migraines may present without a history of headache.[19] Common complaints include acute episodes of vertigo lasting seconds to days, dizziness, imbalance, and spatial disorientation. Other symptoms may include lightheadedness, swimming sensation, heavy headedness, a rising sensation, tingling sensation, a rocking sensation, excessive motion sickness susceptibility. Additionally, transient fluctuating hearing loss, aural fullness, tinnitus, and mild sensorineural hearing loss on audiogram are not uncommon. To define vertigo, the patient explains a sensation of motion when no motion is taking place or an altered sensation with normal motion. In a vestibular migraine, the sensation can oft be described as a "to-and-fro" sensation, and this can complicate diagnosis. Based on the variable duration, this disease can mimic other causes of vertigo. Vertigo and headache do not always present synchronously, in fact, it is rare for both symptoms to present simultaneously. There does not seem to be a consistent pattern of vestibular symptoms during headache presentation.[3][15][20]

A vestibular migraine does not seem to go away. Episodes can be associated with women’s menstrual cycles. Studies have shown that nearly 50% of those diagnosed with probable vestibular migraine progress to definite vestibular migraine according to the previously mentioned Neuheuser criteria. Another study showed that nearly 30% experienced increased frequency of attacks over a 9-year observation period, although nearly 50% experienced a reduced frequency of attacks. Nearly 90% of vestibular migraineurs still report vertiginous attacks after nine years. Additionally, cochlear complaints such as aural fullness, tinnitus, and/or hearing loss during vertigo spells seem to become more common as time progresses.[12]


A thorough history is imperative as there are no pathognomonic imaging studies or available testing consistent with vestibular migraine. Despite this, there are nonspecific findings noted with certain studies. One such example comes with magnetic resonance imaging (MRI). MRI has shown an associated finding consistent with a general migraine. White matter hyperintensities are four times more likely in this group as compared to age and gender-matched controls.[21] Some functional neuroimaging lends some light on general migraine pathophysiology; however, few such reports are available regarding vestibular migraine and may be an area of future exploration and discovery.

Vestibular testing and neurotologic exams typically yield nondiagnostic abnormalities in those with isolated probable or definite vestibular migraines. It must be recognized, that if an individual has Meniere syndrome or BPPV association, they are more likely to have abnormal testing.[16]

Another study has shown an increased incidence of unilateral canal paresis on caloric testing and vestibular hyporesponsiveness or hyperresponsiveness in vestibular migraine patients.[12] One study suggests abnormal sacculocollic pathway (cervical vestibular evoked myogenic potentials (cVEMP)) and normal ocular VEMP (oVEMP) findings in a vestibular migraine compared to healthy controls; however, these findings have not been duplicated.[22] These findings are not unique to vestibular migraine.

Treatment / Management

Current management of a vestibular migraine consists of conventional migraine management as there is currently no accepted specific treatment for this disease.[17][22] Additionally, convincing a patient of the diagnosis can prove difficult and lead to a delay in treatment or absence of treatment. This is understandable based on the fact that vertiginous symptoms are often asynchronous with a headache and may be a difficult connection for the practitioner or patient to grasp.[23]

Sargent’s experience suggests that triptan therapy is rarely of benefit in the acute treatment of a vestibular migraine despite small reports suggesting modest benefit in acute vertigo attacks.[3][24][25] Triptans and calcium-channel-blocking medications have proven ineffective in shortening aura or preventing headaches in general migraines;[23] however, they have not been tested in vestibular migraine. Thus, for acute vestibular migraine only antiemetic and antivertigo therapies are currently recommended.[3]

Current recommendations for vestibular migraine prevention include lifestyle changes such as avoidance of dietary, behavioral, or sleep hygiene triggers.[25] In one retrospective study, caffeine cessation was associated with symptomatic improvement in 15% of the vestibular migraine population tested. This reduction in symptomatology was incomplete, however, and many required further medical therapy. From this study, 75% of those with a vestibular migraine experienced ample relief from lifestyle changes in addition to treatment with nortriptyline or topiramate and did not require further treatment. Nortriptyline gave relief in 46% while topiramate provided relief in 25% in this retrospective study.[23][26] In a separate prospective study, topiramate (50 to 100 mg per day) was shown to reduce the frequency and severity of vertigo and headaches.[27]

A 2017 randomized controlled trial by Liu, et al. demonstrated the efficacy and safety of venlafaxine, flunarizine, and valproic acid in the prophylaxis of vestibular migraine. Each treatment demonstrated unique treatment properties such as venlafaxine which showed an advantage in the treatment of emotional symptoms. Venlafaxine and valproic acid also were shown to be preferable to flunarizine in decreasing the frequency of vertiginous attacks. Valproic acid seemed to be less effective than venlafaxine and flunarizine in decreasing vertigo severity.[28]

The American Headache Society, American Academy of Neurology recommends the following therapies as possibilities for an episodic migraine: butterbur, divalproate, metoprolol, propranolol, timolol, and topiramate.[29] Aside from topiramate, none of these have been evaluated for the treatment of a vestibular migraine specifically; however, it seems that clinicians could consider these as potential treatment options. Other possibilities include amitriptyline and calcium channel blockers.[24] Clinicians could consider other existing comorbidities in conjunction with a vestibular migraine and tailor therapies to treat both or multiple illnesses, for example, nortriptyline for concomitant anxiety, topiramate or propranolol for associated headaches/hypertension.

Physiotherapy may play a role in treating some of the associated sequelae of vestibular migraine which include anxiety, visual dependence, and/or loss of confidence.[23]

Those with interictal symptoms of imbalance could consider vestibular rehabilitation therapy as a potential treatment modality.[30]

Currently, no surgical management is recommended for vestibular migraine and may result in worsening of illness is associated with Meniere syndrome (Wise SR & Sargent EW; presentation 2013).

Differential Diagnosis

Meniere syndrome and BPPV were discussed previously.

It is anticipated that nearly 50% of those with childhood vertigo are related to a migraine. Benign paroxysmal vertigo of childhood is the most common cause of vertigo between the years of 2 and 6 with a prevalence estimated at 2.6% between the ages of 5 and 15.[31] This typically presents with seconds to minutes of vertigo/dizziness, nystagmus, postural imbalance, nausea or vomiting with the return to baseline between episodes. Children may outgrow this condition, as many are relieved from its burden after their sixth birthday.

Chronic subjective dizziness (CSD) is an entity that includes chronic unsteadiness or dizziness without vertigo. Additionally, it presents with hypersensitivity to motion stimuli, poor tolerance of visual stimuli or precision visual tasks. This condition must last three or more months to make the diagnosis. It has been found that CSD often coexists with other recurrent vertigo illnesses.[32]

The following diagnoses commonly replace a vestibular migraine when the patient is followed for an extended period: Meniere syndrome, benign paroxysmal positional vertigo, psychogenic dizziness, and spinocerebellar ataxia. Episodic ataxia type 2 and transient ischemic attacks must be ruled out before making the diagnosis.[3]


The prognosis for these patients remains unknown but anecdotal reports indicate that recurrences are common.


Clinical experience has shown varying levels of disability and responsiveness to treatments amongst the vestibular migraine population.


Neurotologic and/or neurology evaluation are a reasonable recommendation.

Deterrence and Patient Education

Convincing a patient of the diagnosis of a vestibular migraine can prove difficult and lead to delay in treatment or absence of treatment. This is understandable based on the fact that vertiginous symptoms are often asynchronous with a headache and may be a difficult connection for the practitioner or patient to grasp.[23] Medication adherence and close follow-up should be encouraged.

Pearls and Other Issues

A vestibular migraine is an elusive diagnosis with variable presentation and without pathognomonic testing despite significant associated morbidity.

Familiarity with recently accepted Barany Society and the International Headache Society diagnostic criteria is important to make a diagnosis. See below:

  • At least 5 episodes of vestibular symptoms of moderate or severe intensity lasting 5 minutes to 72 hours 
  • Current or previous history of migraine with or without aura according to the ICHD classification
  • One or more migraine features with at least 50% of vestibular episodes: headache with at least 2 of the following characteristics: one-sided location, pulsating quality, moderate or severe pain intensity, or aggravation by routine physical activity; photophobia or phonophobia; visual aura
  • Not better accounted for by another vestibular or ICHD diagnosis

Vestibular migraine can present at any age, although middle-aged women are most commonly affected.

One theory exists that a vestibular migraine may be caused by vestibular end-organ disease; therefore, regular patient monitoring is merited to evaluate for possible contributing morbidity.

A vestibular migraine may be associated with other illnesses such as Meniere syndrome or BPPV. The verdict is currently out regarding the chronology of events/triggers. Do Meniere attacks trigger a vestibular migraine, or does a vestibular migraine give rise to Meniere syndrome features?

Enhancing Healthcare Team Outcomes

The diagnosis and management of vestibular migraine are complex and best done with an interprofessional team. This team may include primary clinicians, neurologists, neurotologists, otolaryngologists, nurses, and pharmacists. There are many treatments for vestibular migraine but there is no specific treatment that works for everyone. Current treatment options include lifestyle changes such as caffeine omission, and avoidance of known dietary, behavioral or sleep hygiene triggers. Prophylactic medications such as topiramate, nortriptyline, propranolol may provide some benefit despite few controlled studies on the matter. Vestibular rehabilitation may play a role. Treatment of associated anxiety is a necessity.

Review Questions


O'Connell Ferster AP, Priesol AJ, Isildak H. The clinical manifestations of vestibular migraine: A review. Auris Nasus Larynx. 2017 Jun;44(3):249-252. [PubMed: 28285826]
Luzeiro I, Luís L, Gonçalves F, Pavão Martins I. Vestibular Migraine: Clinical Challenges and Opportunities for Multidisciplinarity. Behav Neurol. 2016;2016:6179805. [PMC free article: PMC5204080] [PubMed: 28082766]
Sargent EW. The challenge of vestibular migraine. Curr Opin Otolaryngol Head Neck Surg. 2013 Oct;21(5):473-9. [PubMed: 23892794]
Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders: 2nd edition. Cephalalgia. 2004;24 Suppl 1:9-160. [PubMed: 14979299]
Bisdorff A, Von Brevern M, Lempert T, Newman-Toker DE. Classification of vestibular symptoms: towards an international classification of vestibular disorders. J Vestib Res. 2009;19(1-2):1-13. [PubMed: 19893191]
Radtke A, Neuhauser H, von Brevern M, Hottenrott T, Lempert T. Vestibular migraine--validity of clinical diagnostic criteria. Cephalalgia. 2011 Jun;31(8):906-13. [PubMed: 21508087]
Furman JM, Balaban CD. Vestibular migraine. Ann N Y Acad Sci. 2015 Apr;1343:90-6. [PubMed: 25728541]
Bahmad F, DePalma SR, Merchant SN, Bezerra RL, Oliveira CA, Seidman CE, Seidman JG. Locus for familial migrainous vertigo disease maps to chromosome 5q35. Ann Otol Rhinol Laryngol. 2009 Sep;118(9):670-6. [PMC free article: PMC2767209] [PubMed: 19810609]
Lee H, Jen JC, Cha YH, Nelson SF, Baloh RW. Phenotypic and genetic analysis of a large family with migraine-associated vertigo. Headache. 2008 Nov-Dec;48(10):1460-7. [PMC free article: PMC2846425] [PubMed: 18081823]
Lee H, Jen JC, Wang H, Chen Z, Mamsa H, Sabatti C, Baloh RW, Nelson SF. A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet. 2006 Jan 15;15(2):251-8. [PubMed: 16330481]
Neff BA, Staab JP, Eggers SD, Carlson ML, Schmitt WR, Van Abel KM, Worthington DK, Beatty CW, Driscoll CL, Shepard NT. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Ménière's disease, vestibular migraine, and Ménière's disease with concomitant vestibular migraine. Otol Neurotol. 2012 Sep;33(7):1235-44. [PubMed: 22801040]
Radtke A, von Brevern M, Neuhauser H, Hottenrott T, Lempert T. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012 Oct 09;79(15):1607-14. [PubMed: 23019266]
Agarwal K, Bronstein AM, Faldon ME, Mandalà M, Murray K, Silove Y. Visual dependence and BPPV. J Neurol. 2012 Jun;259(6):1117-24. [PubMed: 22113702]
Polensek SH, Tusa RJ. Nystagmus during attacks of vestibular migraine: an aid in diagnosis. Audiol Neurootol. 2010;15(4):241-6. [PubMed: 19893305]
Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013 Jul;12(7):706-15. [PubMed: 23769597]
Eggers SD, Staab JP, Neff BA, Goulson AM, Carlson ML, Shepard NT. Investigation of the coherence of definite and probable vestibular migraine as distinct clinical entities. Otol Neurotol. 2011 Sep;32(7):1144-51. [PubMed: 21799457]
Cherian N. Vertigo as a migraine phenomenon. Curr Neurol Neurosci Rep. 2013 Apr;13(4):343. [PubMed: 23430687]
Murdin L, Davies RA, Bronstein AM. Vertigo as a migraine trigger. Neurology. 2009 Aug 25;73(8):638-42. [PubMed: 19704084]
Strupp M, Versino M, Brandt T. Vestibular migraine. Handb Clin Neurol. 2010;97:755-71. [PubMed: 20816468]
Lempert T. Vestibular migraine. Semin Neurol. 2013 Jul;33(3):212-8. [PubMed: 24057824]
Absinta M, Rocca MA, Colombo B, Copetti M, De Feo D, Falini A, Comi G, Filippi M. Patients with migraine do not have MRI-visible cortical lesions. J Neurol. 2012 Dec;259(12):2695-8. [PubMed: 22714135]
Hong SM, Kim SK, Park CH, Lee JH. Vestibular-evoked myogenic potentials in migrainous vertigo. Otolaryngol Head Neck Surg. 2011 Feb;144(2):284-7. [PubMed: 21493432]
Bisdorff AR. Management of vestibular migraine. Ther Adv Neurol Disord. 2011 May;4(3):183-91. [PMC free article: PMC3105632] [PubMed: 21694818]
Cherchi M, Hain TC. Migraine-associated vertigo. Otolaryngol Clin North Am. 2011 Apr;44(2):367-75, viii-ix. [PubMed: 21474011]
Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003 Mar 11;60(5):882-3. [PubMed: 12629256]
Mikulec AA, Faraji F, Kinsella LJ. Evaluation of the efficacy of caffeine cessation, nortriptyline, and topiramate therapy in vestibular migraine and complex dizziness of unknown etiology. Am J Otolaryngol. 2012 Jan-Feb;33(1):121-7. [PubMed: 21704423]
Gode S, Celebisoy N, Kirazli T, Akyuz A, Bilgen C, Karapolat H, Sirin H, Gokcay F. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010 Jan;50(1):77-84. [PubMed: 19656221]
Liu F, Ma T, Che X, Wang Q, Yu S. The Efficacy of Venlafaxine, Flunarizine, and Valproic Acid in the Prophylaxis of Vestibular Migraine. Front Neurol. 2017;8:524. [PMC free article: PMC5641552] [PubMed: 29075232]
Loder E, Burch R, Rizzoli P. The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines. Headache. 2012 Jun;52(6):930-45. [PubMed: 22671714]
Whitney SL, Wrisley DM, Brown KE, Furman JM. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope. 2000 Sep;110(9):1528-34. [PubMed: 10983955]
Jahn K. Vertigo and balance in children--diagnostic approach and insights from imaging. Eur J Paediatr Neurol. 2011 Jul;15(4):289-94. [PubMed: 21571558]
Ruckenstein MJ, Staab JP. Chronic subjective dizziness. Otolaryngol Clin North Am. 2009 Feb;42(1):71-7, ix. [PubMed: 19134491]

Disclosure: Daniel Hilton declares no relevant financial relationships with ineligible companies.

Disclosure: Carl Shermetaro declares no relevant financial relationships with ineligible companies.

Copyright © 2023, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

Bookshelf ID: NBK507859PMID: 29939636


  • PubReader
  • Print View
  • Cite this Page

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...